Stock Comparison
CRL vs DHR
Charles River Laboratories and Danaher Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$10.39B
$138.86B
P/E (TTM)
—
38.0
Forward P/E
19.4
23.2
Price/Sales
2.6
5.6
Price/Book
3.5
2.6
EV/EBITDA
45.6
21.4
Dividend Yield
—
0.71%
Profitability
Net Margin
-4.59%
14.90%
Operating Margin
15.90%
22.90%
Return on Equity
-5.87%
7.08%
Return on Assets
4.26%
4.19%
Growth (YoY)
Revenue Growth
1.20%
3.70%
Earnings Growth
-17.30%
9.80%
Price & Risk
Beta
1.4
0.8
52-Week High
$228.88
$241.78
52-Week Low
$144.26
$160.60
Analyst Target
$215.33
$242.35
Compare CRL and DHR your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.